TELA Bio, Inc. (TELA) Misses Q3 EPS by 2c

TELA Bio, Inc. (NASDAQ: TELA) reported Q3 EPS of ($0.64), $0.02 worse than the analyst estimate of ($0.62). Revenue for the quarter came in at $11.2 million versus the consensus estimate of $10.86 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Canaccord Starts L1 Group Ltd (L1G:AU) at Buy
• Anthropic delays planned IPO from October to November - WSJ